Pharmacologically delivered NLRP3 (MCC950, BHB) or caspase-1 (VX-765) inhibitors prevent EoE pathogenesis in mice challenged with Aspergillus fumigatus or corn extract. This evidence concerns the gene CASP1 and eosinophilic esophagitis.